Article
Author(s):
In light of National Hair Loss Awareness month, we’ve aggregated our top 10 hair loss articles of 2021 so far.
National Hair Loss Awareness month highlights the ongoing need for continued education on the varying types of alopecia and its treatment options. In support, Dermatology Times® has aggregated our top 10 hair loss articles of 2021 so far.
1. Trichoscopy Advances Hair and Scalp Disease Diagnoses
Trichoscopy, which is based on dermoscopy, can be a valuable tool for diagnosing conditions that cause hair loss and inflammatory scalp disease.
2. Ritlecitinib Delivers Topline Results in Alopecia Areata Study
Ritlecitinib, an investigational covalent kinase inhibitor, achieved its primary endpoint and demonstrated statistically significant efficacy compared to placebo in treating alopecia areata.
3. Dupilumab for Pediatric Alopecia Areata
Hair regrowth was observed after starting dupilumab treatment in some pediatric patients with a history of severe and refractory alopecia areata (AA) and concomitant atopic dermatitis (AD).
4. Nutrafol Launches Postpartum Nutraceutical
Nutrafol launches a new nutraceutical, called Postpartum, aimed at helping women’s hair health post-pregnancy.
5. Baricitinib Shows Hair Regrowth in Phase 3 Study for AA
Eli Lilly and Incyte announce results from its phase 3 study evaluating baricitinib 2 mg and 4 mg for the treatment of alopecia areata, making it the first Phase 3 study with top-line results in patients with the hair disorder.
6. BioPhotas Announces Celluma RESTORE for Hair Loss
BioPhotas announces the new addition to their Celluma light therapy device line, Celluma RESTORE, for the treatment of hair loss, aging skin, and general pain.
7. First Genetic Test for Hair Loss
Fagron North America, a pharmaceutical compounding company, introduced TrichoTest, a genetic test developed to support assessment and treatment of alopecia.
8. Hair Restoration Goes High-Tech
Futuristic tools including robotics and new types of lasers are just some of the therapeutic innovations aimed at slowing hair loss and increasing hair growth.
9. Biomarker Associated with Hair Loss Also Linked to COVID-19 Severity
New study data presented at EADV demonstrated an association between COVID-19 severity in male patients and the sex hormone androgen.
10. Study Examines Finasteride Risks for Younger Males
A recent study shows an association between finasteride use and psychological adverse events (AEs) including suicidality. Dermatologists should weigh benefits and risks carefully when considering finasteride for certain patients with hair loss, according to one expert.